Article Text

Download PDFPDF
CASE REPORT
Granulomatosis with polyangiitis with intestinal involvement successfully treated with rituximab and surgery
  1. Hitoshi Sato1,
  2. Kentaro Shima2,
  3. Hanae Sakata1 and
  4. Takashi Ohtoh3
  1. 1 Internal Medicine, South Miyagi Medical Center, Ogawara, Japan
  2. 2 Surgery, South Miyagi Medical Center, Ogawara, Japan
  3. 3 Pathology, South Miyagi Medical Center, Ogawara, Japan
  1. Correspondence to Dr Hitoshi Sato, hitoshisa{at}gmail.com

Abstract

Intestinal perforation is a rare and life-threatening complication in granulomatosis with polyangiitis (GPA). A 55-year-old Japanese man who had been undergoing maintenance haemodialysis was diagnosed with GPA via a pathologically proven nasal granuloma and proteinase 3-antineutrophil cytoplasmic antibody-positive status. He was started on 60 mg prednisolone. Haematochezia was observed due to the colon ulcer after treatment initiation. Two doses of intravenous cyclophosphamide were administered every 2 weeks. Despite the treatment, there were two episodes of severe abdominal pain with peritonitis within a week. Perforation of descending colon and severe ischaemia of the ascending colon was observed during each emergency laparotomy, and ileostomy was performed. Vasculitis in the small vessels was confirmed. In conclusion, patient with severe intestinal involvement and who was unresponsive to conventional therapy was treated with surgery followed by rituximab administration, and remission was achieved.

  • vasculitis
  • gastrointestinal surgery
  • gastroenterology
View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors HSat: conception and design; KS, HSak: patient care; KS, HSak and TO: acquisition of data, and/or HSak, TO: analysis and interpretation of data. HSat: drafting of the manuscript and/or critical revision of the manuscript for important intellectual content.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.